Differential effects of stress and amphetamine administration on Fos-like protein expression in corticotropin releasing factor-neurons of the rat brain-Reference-Cited by-同舟云学术

Differential effects of stress and amphetamine administration on Fos-like protein expression in corticotropin releasing factor-neurons of the rat brain

Published:2007 Issue:6 Volume:67 Page:702-714
ISSN:1932-8451
Container-title:Developmental Neurobiology
language:en
Short-container-title:Devel Neurobio

Author:

Rotllant David,Nadal Roser,Armario Antonio

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Developmental Neuroscience

Reference83 articles.

1. Expression of c-fos in restricted areas of the basal forebrain and brainstem following single or combined intraventricular infusions of vasopressin and corticotropin-releasing factor

2. Hypothalamic Control of Adrenocorticotropin Secretion: Advances since the Discovery of 41-Residue Corticotropin-Releasing Factor

3. Expression of c-fos in regions of the basal limbic forebrain following intra-cerebroventricular corticotropin-releasing factor in unstressed or stressed male rats

4. Amphetamine-Induced Behavior, Dopamine Release, and c-fosmRNA Expression: Modulation by Environmental Novelty

5. CRF and CRF Receptors: Role in Stress Responsivity and Other Behaviors

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Restricted cafeteria feeding and treadmill exercise improved body composition, metabolic profile and exploratory behavior in obese male rats;Scientific Reports;2022-11-15

2. Amphetamine exposure alters behaviors, and neuronal and neurochemical activation in the brain of female prairie voles;Neuroscience;2022-08

3. Stress hormones mediate developmental plasticity in vertebrates with complex life cycles;Neurobiology of Stress;2021-05

4. Individual differences in the neuroendocrine response of male rats to emotional stressors are not trait-like and strongly depend on the intensity of the stressors;Psychoneuroendocrinology;2021-03

5. Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications;Pharmaceuticals;2020-07-18